AlphaSense is a market intelligence and search platform used by the world’s leading companies and financial institutions. Since 2011, our AI-based technology has helped professionals make smarter business decisions by delivering insights from an extensive universe of public and private content—including company filings, event transcripts, expert calls, news, trade journals, and equity research. Our platform is trusted by over 3,500 enterprise customers, including a majority of the S&P 500. Headquartered in New York City, AlphaSense employs over 1,000 people across offices in the U.S., U.K., Germany, Finland, and India. For more information, please visit www.alpha-sense.com. | The world’s most sophisticated companies rely on AlphaSense to remove uncertainty from decision-making. With market intelligence and search built on proven AI, AlphaSense delivers insights that matter from content you can trust. Our universe of public and private content includes equity research, company filings, event transcripts, expert calls, news, trade journals, and clients’ own research content. Founded in 2011, AlphaSense is headquartered in New York City with over 1,000 people across the globe and offices in the U.S., U.K., Finland, India, and Singapore. For more information, please visit www.alpha-sense.com. | AlphaSense is how the world’s most sophisticated companies remove uncertainty from their decision-making. With market intelligence and search built on proven AI, AlphaSense quickly delivers relevant insights from a trustworthy universe of public and private content—including equity research, company filings, event transcripts, expert calls, news, trade journals, and clients’ own research content. Headquartered in New York City, AlphaSense employs over 1,000 people across offices in the U.S., U.K., Finland, India, and Singapore. For more information, please visit www.alpha-sense.com. | AlphaSense is the AI platform redefining market intelligence and workflow orchestration, trusted by thousands of leading organizations to drive faster, more confident decisions in business and finance. The platform combines domain specific AI with a vast content universe of over 500 million premium business documents — including equity research, earnings calls, expert interviews, filings, news, and internal proprietary content. Purpose-built for speed, accuracy, and enterprise-grade security, AlphaSense helps teams extract critical insights, uncover market-moving trends, and automate complex workflows with high quality outputs. With AI solutions like Generative Search, Generative Grid, and Deep Research, AlphaSense delivers the clarity and depth professionals need to navigate complexity and obtain accurate, real-time information quickly. For more information, visit www.alpha-sense.com. | AlphaSense is the AI platform redefining market intelligence and workflow orchestration, trusted by thousands of leading organizations to drive faster, more confident decisions in business and finance. The platform combines domain specific AI with a vast content universe of over 500 million premium business documents. Purpose-built for speed, accuracy, and enterprise-grade security, AlphaSense helps teams extract critical insights, uncover market-moving trends, and automate complex workflows.
AGMI Group
AGMI Group is a global advisory and execution firm specializing in strategy and operations for life sciences and healthcare companies. With deep roots in biopharma, medtech, and diagnostics, we partner with industry leaders, venture-backed innovators, and private capital to drive value across R&D, commercialization, and investment cycles. Founded by a team of ex-McKinsey and industry executives, AGMI combines strategic rigor with hands-on execution, focusing on four core areas: 1. R&D Portfolio Strategy & IND Readiness (Preclinical to Translational) 2. Commercial and Go-to-Market Strategy 3. Private Capital – Due Diligence & Equity Story Development 4. Operational Excellence & PMO Execution AGMI Group operates globally with hubs in Boston, Silicon Valley, and Puerto Rico, supporting clients across the U.S., LATAM, Japan, and Southeast Asia. Our team includes MDs, PhDs, and operators who bridge science and strategy, execution and insight—driving results where it matters most.
AAPharmaSyn, LLC
AAPharmaSyn, LLC (Ann Abor based and US owned) is a global research organization that provides Superior Drug Discovery Chemistry Solutions. We specialize in: 1. Medicinal Chemistry (hit to lead, lead optimization and scale up, SAR, etc. mg to 1 kg); 2. Process Research and Development (route scouting, route optimization, scale up, etc. up to 5 kg); 3. Custom and Exotic Research Tool (unique ADCs, lipids, flavonoids, carbohydrates, intermediates, etc.). AAPharmaSyn is built on the premise that application of the fundamental principles of synthetic organic chemistry toward salient problems leads to superior results. Our investment in how we solve problems and execute synthetic strategy saves money and time. | AAPharmaSyn, LLC is a US-based and owned global contract research organization (CRO) specializing in medicinal chemistry, drug discovery, process development, and non-GMP manufacturing. Headquartered in Ann Arbor, Michigan, the company was founded in 2006 by former Pfizer scientists and is staffed by senior chemists with deep expertise in organic synthesis, medicinal chemistry, and chemical process optimization. Since its inception, AAPharmaSyn has demonstrated consistent growth by delivering high-quality, reliable, and innovative solutions to a diverse client base—including government agencies, pharmaceutical and biotechnology companies of all sizes, and academic research institutions. The company’s core strengths include rigorous execution, scientific creativity, proactive problem-solving, and transparent communication. To further expand its capabilities and market reach, AAPharmaSyn actively pursues strategic collaborations with industrial partners and academic institutions, supporting the development of new products, acquisition of enabling platform technologies, and entry into emerging markets. Company Brief: 1. History: Founded in 2006 (ex-Pfizer). Based in Ann Arbor, MI (all work performed locally). BBB A+ rating. >800 projects successfully completed. 2. Team: Each team member has 10+ years of synthetic organic chemistry experience. All Ph.D.’s with multiple publications and patents. Academic pedigree: Yale, Princeton, Harvard, UC Berkeley, Purdue, UM. 3. Key Attributes: communication and problem-solving 4. Reputation: Our client testimonials speak to the value we deliver. (https://aapharmasyn.com/customer-testimonials/) Key services: • Medicinal Chemistry: high-throughput screening outcome triage, lead development, scaffold-hopping, structure-based design, structure activity relationship (SAR) development • Custom Organic and Peptide Synthesis: including ADC’s, complex carbohydrates, lipids, API impurities, intermediates, metabolites, etc. • Route Scouting and de novo Process Development: non-GMP scale-up (up to 5 kg batch size)